Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes

In Seok Park, Hideyasu Kiyomoto, Sherry L. Abboud, Hanna E. Abboud

Research output: Contribution to journalArticle

168 Citations (Scopus)

Abstract

The earliest manifestations of type I diabetic nephropathy include mesangial matrix expansion, basement membrane thickening, and renal hypertrophy. Transforming growth factor (TGF)-β, a potent inducer of matrix protein synthesis, is a prime candidate to mediate the glomerular changes observed in diabetes. However, the temporal expression of TGF-β and matrix proteins during the early stage of diabetic nephropathy has not been clearly defined. Using in situ hybridization and immunohistochemistry, we determined the expression of TGF-β and type IV collagen mRNAs and proteins in glomeruli and interstitium of diabetic rats 3, 7, and 14 days after streptozotocin (STZ) administration. There was a marked increase in the expression of TGF- β and α1 (IV) procollagen mRNAs in glomerular and tubulointerstitial cells as early as 3 days after induction of diabetes, an effect that persisted for 14 days. A concomitant increase in TGF-β and type IV collagen proteins was also observed at each time point. Insulin treatment substantially inhibited the increased expression of TGF-β and collagen type IV mRNAs and proteins. We conclude that TGF-β is increased in glomeruli during the early phase of rapid renal growth in diabetes. These findings suggest that TGF-β may be a key factor involved in the pathogenesis of basement membrane thickening and extracellular matrix accumulation. Inhibition of TGF-β and type IV collagen expression by insulin treatment suggests that they may be useful structural markers for determining the efficacy of therapeutic intervention during early diabetic nephropathy.

Original languageEnglish (US)
Pages (from-to)473-480
Number of pages8
JournalDiabetes
Volume46
Issue number3
StatePublished - Mar 1997

Fingerprint

Experimental Diabetes Mellitus
Transforming Growth Factors
Collagen
Diabetic Nephropathies
Proteins
Basement Membrane
Messenger RNA
Insulin
Kidney
Procollagen
Collagen Type IV
Streptozocin
Hypertrophy
In Situ Hybridization
Extracellular Matrix
Therapeutics
Immunohistochemistry

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Park, I. S., Kiyomoto, H., Abboud, S. L., & Abboud, H. E. (1997). Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes, 46(3), 473-480.

Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. / Park, In Seok; Kiyomoto, Hideyasu; Abboud, Sherry L.; Abboud, Hanna E.

In: Diabetes, Vol. 46, No. 3, 03.1997, p. 473-480.

Research output: Contribution to journalArticle

Park, IS, Kiyomoto, H, Abboud, SL & Abboud, HE 1997, 'Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes', Diabetes, vol. 46, no. 3, pp. 473-480.
Park, In Seok ; Kiyomoto, Hideyasu ; Abboud, Sherry L. ; Abboud, Hanna E. / Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. In: Diabetes. 1997 ; Vol. 46, No. 3. pp. 473-480.
@article{1e35eabf704f4d99a444427a6158c29c,
title = "Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes",
abstract = "The earliest manifestations of type I diabetic nephropathy include mesangial matrix expansion, basement membrane thickening, and renal hypertrophy. Transforming growth factor (TGF)-β, a potent inducer of matrix protein synthesis, is a prime candidate to mediate the glomerular changes observed in diabetes. However, the temporal expression of TGF-β and matrix proteins during the early stage of diabetic nephropathy has not been clearly defined. Using in situ hybridization and immunohistochemistry, we determined the expression of TGF-β and type IV collagen mRNAs and proteins in glomeruli and interstitium of diabetic rats 3, 7, and 14 days after streptozotocin (STZ) administration. There was a marked increase in the expression of TGF- β and α1 (IV) procollagen mRNAs in glomerular and tubulointerstitial cells as early as 3 days after induction of diabetes, an effect that persisted for 14 days. A concomitant increase in TGF-β and type IV collagen proteins was also observed at each time point. Insulin treatment substantially inhibited the increased expression of TGF-β and collagen type IV mRNAs and proteins. We conclude that TGF-β is increased in glomeruli during the early phase of rapid renal growth in diabetes. These findings suggest that TGF-β may be a key factor involved in the pathogenesis of basement membrane thickening and extracellular matrix accumulation. Inhibition of TGF-β and type IV collagen expression by insulin treatment suggests that they may be useful structural markers for determining the efficacy of therapeutic intervention during early diabetic nephropathy.",
author = "Park, {In Seok} and Hideyasu Kiyomoto and Abboud, {Sherry L.} and Abboud, {Hanna E.}",
year = "1997",
month = "3",
language = "English (US)",
volume = "46",
pages = "473--480",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes

AU - Park, In Seok

AU - Kiyomoto, Hideyasu

AU - Abboud, Sherry L.

AU - Abboud, Hanna E.

PY - 1997/3

Y1 - 1997/3

N2 - The earliest manifestations of type I diabetic nephropathy include mesangial matrix expansion, basement membrane thickening, and renal hypertrophy. Transforming growth factor (TGF)-β, a potent inducer of matrix protein synthesis, is a prime candidate to mediate the glomerular changes observed in diabetes. However, the temporal expression of TGF-β and matrix proteins during the early stage of diabetic nephropathy has not been clearly defined. Using in situ hybridization and immunohistochemistry, we determined the expression of TGF-β and type IV collagen mRNAs and proteins in glomeruli and interstitium of diabetic rats 3, 7, and 14 days after streptozotocin (STZ) administration. There was a marked increase in the expression of TGF- β and α1 (IV) procollagen mRNAs in glomerular and tubulointerstitial cells as early as 3 days after induction of diabetes, an effect that persisted for 14 days. A concomitant increase in TGF-β and type IV collagen proteins was also observed at each time point. Insulin treatment substantially inhibited the increased expression of TGF-β and collagen type IV mRNAs and proteins. We conclude that TGF-β is increased in glomeruli during the early phase of rapid renal growth in diabetes. These findings suggest that TGF-β may be a key factor involved in the pathogenesis of basement membrane thickening and extracellular matrix accumulation. Inhibition of TGF-β and type IV collagen expression by insulin treatment suggests that they may be useful structural markers for determining the efficacy of therapeutic intervention during early diabetic nephropathy.

AB - The earliest manifestations of type I diabetic nephropathy include mesangial matrix expansion, basement membrane thickening, and renal hypertrophy. Transforming growth factor (TGF)-β, a potent inducer of matrix protein synthesis, is a prime candidate to mediate the glomerular changes observed in diabetes. However, the temporal expression of TGF-β and matrix proteins during the early stage of diabetic nephropathy has not been clearly defined. Using in situ hybridization and immunohistochemistry, we determined the expression of TGF-β and type IV collagen mRNAs and proteins in glomeruli and interstitium of diabetic rats 3, 7, and 14 days after streptozotocin (STZ) administration. There was a marked increase in the expression of TGF- β and α1 (IV) procollagen mRNAs in glomerular and tubulointerstitial cells as early as 3 days after induction of diabetes, an effect that persisted for 14 days. A concomitant increase in TGF-β and type IV collagen proteins was also observed at each time point. Insulin treatment substantially inhibited the increased expression of TGF-β and collagen type IV mRNAs and proteins. We conclude that TGF-β is increased in glomeruli during the early phase of rapid renal growth in diabetes. These findings suggest that TGF-β may be a key factor involved in the pathogenesis of basement membrane thickening and extracellular matrix accumulation. Inhibition of TGF-β and type IV collagen expression by insulin treatment suggests that they may be useful structural markers for determining the efficacy of therapeutic intervention during early diabetic nephropathy.

UR - http://www.scopus.com/inward/record.url?scp=0031053824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031053824&partnerID=8YFLogxK

M3 - Article

C2 - 9032105

AN - SCOPUS:0031053824

VL - 46

SP - 473

EP - 480

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -